Shaolin Capital Management’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-330,547
| Closed | -$4.33K | – | 316 |
|
|
2024
Q3 | $4.33K | Sell |
330,547
-119,453
| -27% | -$1.57K | ﹤0.01% | 234 |
|
|
2024
Q2 | $18.9K | Hold |
450,000
| – | – | ﹤0.01% | 225 |
|
|
2024
Q1 | $23.4K | Hold |
450,000
| – | – | ﹤0.01% | 208 |
|
|
2023
Q4 | $22.5K | Sell |
450,000
-200,000
| -31% | -$10K | ﹤0.01% | 259 |
|
|
2023
Q3 | $143K | Buy |
+650,000
| New | +$143K | 0.01% | 237 |
|
|
2023
Q2 | – | Sell |
-600,000
| Closed | -$25K | – | 448 |
|
|
2023
Q1 | $25K | Buy |
600,000
+104,362
| +21% | +$4.35K | ﹤0.01% | 524 |
|
|
2022
Q4 | $25K | Hold |
495,638
| – | – | ﹤0.01% | 545 |
|
|
2022
Q3 | $28K | Hold |
495,638
| – | – | ﹤0.01% | 660 |
|
|
2022
Q2 | $45K | Sell |
495,638
-2,200
| -0.4% | -$200 | ﹤0.01% | 700 |
|
|
2022
Q1 | $179K | Buy |
+497,838
| New | +$179K | ﹤0.01% | 581 |
|